The Patent Finder

Dabur Research Foundation

Also on record
Records under this name other than patents Dabur Research Foundation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Dabur Research Foundation

PatentTitleStatus Expires Confidence
US 6,322,817Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
Formerly held
Term ended
Term ended Sep 23, 2019 · From the USPTO record
Term endedTerm ended Sep 23, 2019From the USPTO record
US 6,365,191Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
Formerly held
Term ended
Term ended Sep 23, 2019 · From the USPTO record
Term endedTerm ended Sep 23, 2019From the USPTO record
US 6,670,345Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
Formerly held
Lapsed on the fee record
Ended Dec 30, 2015 · From the USPTO record
Lapsed on the fee recordEnded Dec 30, 2015From the USPTO record
US 6,608,174Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
Formerly held
Lapsed on the fee record
Ended Aug 19, 2015 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2015From the USPTO record
US 6,596,692Substance P analogs for the treatment of cancer
Formerly held
Lapsed on the fee record
Ended Jul 22, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 22, 2015From the USPTO record
US 7,179,937Cyclopentenone derivatives for cancer therapy
Formerly held
Lapsed on the fee record
Ended Feb 20, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 20, 2015From the USPTO record
US 7,173,006Drug comprising synthetic peptide analogs for the treatment of cancer
Formerly held
Lapsed on the fee record
Ended Feb 6, 2015 · From the USPTO record
Lapsed on the fee recordEnded Feb 6, 2015From the USPTO record
US 6,489,297Vasoactive intestinal peptide analogs
Formerly held
Lapsed on the fee record
Ended Dec 3, 2014 · From the USPTO record
Lapsed on the fee recordEnded Dec 3, 2014From the USPTO record
US 7,781,398Drug comprising synthetic peptide analogs for the treatment of cancer
Formerly held
Lapsed on the fee record
Ended Aug 24, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 24, 2014From the USPTO record
US 7,094,755Vasoactive intestinal peptide analogs
Formerly held
Lapsed on the fee record
Ended Aug 22, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2014From the USPTO record
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited